Acesso livre
Acesso livre

Terapia Intensiva

Breve revisão | Evolução do manejo da sedação na unidade de terapia intensiva.

4 Ago, 2022 | 14:10h

Evolution of sedation management in the intensive care unit (ICU) – Intensive Care Medicine (se o acesso a este link for pago, tente este)

 

Comentário no Twitter

 

Revisão | Tratamento da descompensação hepática na doença hepática avançada (comprometimento renal, insuficiência hepática, insuficiência suprarrenal e complicações cardiopulmonares).

4 Ago, 2022 | 14:02h

Management of Liver Decompensation in Advanced Liver Disease (Renal Impairment, Liver Failure, Adrenal Insufficiency, Cardiopulmonary Complications) – Clinical Drug Investigation

 

Revisão | Manifestações cutâneas da lesão renal aguda.

4 Ago, 2022 | 14:00h

Cutaneous manifestations of acute kidney injury – Clinical Kidney Journal

 

Revisão | Tratamento da lesão renal aguda em pacientes oncológicos.

4 Ago, 2022 | 13:59h

Treatment of acute kidney injury in cancer patients – Clinical Kidney Journal

Conteúdos relacionados:

Onconephrology: Update in Anticancer Drug-Related Nephrotoxicity – Nephron

Acute Kidney Injury in Critically Ill Patients with Cancer – Clinical Journal of the American Society of Nephrology

Nephrotoxicity of cancer therapeutic drugs: Focusing on novel agents – Kidney Research and Clinical Practice

KDIGO Controversies Conference on onco-nephrology: understanding kidney impairment and solid-organ malignancies, and managing kidney cancer – Kidney International

 

Breve revisão | Monitoramento da dor na unidade de terapia intensiva.

2 Ago, 2022 | 13:25h

Monitoring pain in the intensive care unit (ICU) – Intensive Care Medicine (se o acesso a este link for pago, tente este)

 

Comentário no Twitter

 

M-A | Probióticos na doença crítica.

2 Ago, 2022 | 13:23h

Probiotics in Critical Illness: A Systematic Review and Meta-Analysis of Randomized Controlled Trials – Critical Care Medicine (gratuito por tempo limitado)

 

Comentário no Twitter

 

M-A | Estratégia de suporte respiratório em adultos com insuficiência respiratória hipoxêmica aguda.

2 Ago, 2022 | 13:15h

Respiratory support strategy in adults with acute hypoxemic respiratory failure: a systematic review and network meta-analysis – JA Clinical Reports

 

Estudo de coorte | Análise de prescrições para terapia antiplaquetária dupla após AVC isquêmico agudo.

1 Ago, 2022 | 15:09h

Analysis of Prescriptions for Dual Antiplatelet Therapy After Acute Ischemic Stroke – JAMA Network Open

Conteúdos relacionados:

Dual antiplatelet therapy with aspirin and clopidogrel for acute high risk transient ischaemic attack and minor ischaemic stroke – The BMJ

Multiple versus fewer antiplatelet agents for preventing early recurrence after ischaemic stroke or transient ischaemic attack – Cochrane Library

2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association – Stroke

Stroke and transient ischaemic attack in over 16s: diagnosis and initial management – National Institute for Health and Care Excellence

Dual Antiplatelet Therapy Versus Aspirin in Patients With Stroke or Transient Ischemic Attack: Meta-Analysis of Randomized Controlled Trials – Stroke

Efficacy and Safety of Using Dual Versus Monotherapy Antiplatelet Agents in Secondary Stroke Prevention: Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials – Circulation

 

Comentário no Twitter

 

Revisão | Exames de imagem na síndrome da angústia respiratória aguda: passado, presente e futuro.

18 Jul, 2022 | 13:38h

Imaging the acute respiratory distress syndrome: past, present and future – Intensive Care Medicine

 

Comentário no Twitter

 

Estudo randomizado | Tixagevimabe-cilgavimabe para tratamento de pacientes internados com COVID-19.

18 Jul, 2022 | 13:36h

Tixagevimab–cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trial – The Lancet Respiratory Medicine

Comentário: The potential of tixagevimab–cilgavimab for treating hospitalized COVID-19 patients – News Medical

Conteúdos relacionados:

Efficacy and safety of intramuscular administration of tixagevimab–cilgavimab for early outpatient treatment of COVID-19 (TACKLE): a phase 3, randomised, double-blind, placebo-controlled trial – The Lancet Respiratory Medicine

Intramuscular AZD7442 (Tixagevimab–Cilgavimab) for Prevention of Covid-19 – New England Journal of Medicine

 

Comentário no Twitter

 

Mantenha-se atualizado em sua especialidade

 

Escolha quantas especialidades quiser.